Company Description
Basel Medical aims to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management.
We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical, comprising four orthopedic specialists and one neurosurgery specialist.
The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities.
| Country | Singapore |
| Founded | 2001 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Raymond Wai Man Cheung |
Contact Details
Address: 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, 258499 Singapore | |
| Phone | +65 6291 9188 |
| Website | baselmedical.com |
Stock Details
| Ticker Symbol | BMGL |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | SGD |
| CIK Code | 0002004489 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Raymond Wai Man Cheung | Director and Chief Executive Officer |
| Jianing Lu | Director and Chief Financial Officer |
| Vincent Wee Keong Teo | Chief Partnership Officer |
| Darren Yen Feng Chhoa | Chief Health Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | FWP | Free Writing Prospectus |
| Dec 3, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Nov 14, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Nov 4, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 13, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Aug 29, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 21, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| May 8, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Mar 18, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Feb 9, 2024 | DRS | [Cover] Draft Registration Statement |